Discovery and identification of quality markers of Chinese medicine based on pharmacokinetic analysis

被引:39
作者
He Jun [1 ]
Feng Xinchi [2 ]
Wang Kai [2 ]
Liu Changxiao [2 ,3 ]
Qiu Feng [1 ,2 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 300193, Peoples R China
[2] Tianjin Univ Tradit Chinese Med, Sch Chinese Mat Med, 312 Anshanxi Rd, Tianjin 300193, Peoples R China
[3] Tianjin Inst Pharmaceut Res, Res Ctr New Drug Evaluat, Tianjin 300193, Peoples R China
基金
中国国家自然科学基金;
关键词
Chinese medicine; Therapeutic material basis; Q-marker; Quality control; Metabolites; Pharmacokinetic analysis; RAT PLASMA APPLICATION; MS/MS METHOD; METABOLITES; PERIPLOGENIN; ASSAY;
D O I
10.1016/j.phymed.2018.02.008
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Quality control of Chinese medicine (CM) is an effective measure to ensure the safety and efficacy of CM in clinical practice, which is also a key factor to restrict the modernization process of CM. Various chemical components exist in CM and the determination of several chemical components is the main approach for quality control of vast majority of CM in the present. However, many components determined lack not only specificity, but also biological activities. This is bound to greatly reduce the actual value of quality standard of CM. Purpose: Professor Changxiao Liu proposed the "quality marker" (Q-marker) concept to ensure the standardization and rationalization for the quality control of CM. As we all know, CMs are taken orally in most cases and could be extensively metabolized in vivo. Both prototype components and the metabolites could be the actual therapeutic material basis. Pharmacokinetic studies could benefit the elucidation of actual therapeutic material basis which is closely related to the identification of Q-markers. Therefore, a new strategy about Q-marker was proposed based on the pharmacokinetic analysis of CM, hoping to provide some ideas for the discovery and identification of Q-marker. Methods: The relationship between pharmacokinetic studies and the identification of Q-markers was demonstrated in this review and a new strategy was proposed. Starting from the pharmacokinetic analysis, reverse tracing of the prototype active components and the potential prodrugs in CM were conducted first and the therapeutic material basis were identified as Q-markers. Then, modern analytical techniques and methods were applied to obtain comprehensive quality control for these constituents. Several CMs including gingko biloba, ginseng, Periplocae Cortex, Mori Cortex, Bupleuri Radix and Scutellariae Radix were listed as examples to clarify how the new strategy could be applied. Conclusion: Pharmacokinetic studies play an important role for the elucidation of therapeutic material basis of CM and the identification of Q-markers and it should be taken into account during the process of the investigation of Q-marker.
引用
收藏
页码:182 / 186
页数:5
相关论文
共 34 条
[1]   A validated LC-MS/MS method for determination of periplogenin in rat plasma and its application in pharmacokinetic study [J].
Bo, Fang ;
Dou, Ting ;
Wang, Xingrui ;
Donkor, Paul Owusu ;
Ouyang, Huizi ;
Chang, Yanxu ;
Tu, Yaru ;
Gao, Xiumei ;
He, Jun .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2015, 990 :80-83
[2]  
Chen C., 2017, J CHIN MED MAT, V40, P122
[3]   A rapid integrated bioactivity evaluation system based on near-infrared spectroscopy for quality control of Flos Chrysanthemi [J].
Ding, Guoyu ;
Li, Baiqing ;
Han, Yanqi ;
Liu, Aina ;
Zhang, Jingru ;
Peng, Jiamin ;
Jiang, Min ;
Hou, Yuanyuan ;
Bai, Gang .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 131 :391-399
[4]   Pharmacokinetics and bioavailability of a Ginkgo biloba extract [J].
Drago, F ;
Floriddia, ML ;
Cro, M ;
Giuffrida, S .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2002, 18 (02) :197-202
[5]  
Guo DA, 2017, CHIN HERB MED, V9, P1, DOI [10.1016/S1674-6384(17)60069-8, 10.1016/s1674-6384(17)60069-8]
[6]   A validated LC-MS/MS assay for the simultaneous determination of periplocin and its two metabolites, periplocymarin and periplogenin in rat plasma: Application to a pharmacokinetic study [J].
He, Jun ;
Bo, Fang ;
Tu, Yaru ;
Azietaku, John Teye ;
Dou, Ting ;
Ouyang, Huizi ;
Chang, Yanxu ;
Liu, Hong ;
Gao, Xiumei .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 114 :292-295
[7]  
[黄琴伟 Huang Qinwei], 2016, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V33, P615
[8]   Comparative pharmacokinetic study of baicalin and its metabolites after oral administration of baicalin and Chaiqin Qingning capsule in normal and febrile rats [J].
Huo, Xiao-Kui ;
Wang, Bo ;
Zheng, Lu ;
Cong, Hai-Jian ;
Xiang, Ting ;
Wang, Shu-mei ;
Sun, Cheng-peng ;
Wang, Chao ;
Zhang, Lin ;
Deng, Sa ;
Wu, Bin ;
Ma, Xiao-Chi .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2017, 1059 :14-20
[9]  
[江振作 Jiang Zhenzuo], 2016, [中草药, Chinese Traditional and Herbal Drugs], V47, P4127
[10]  
[阚启明 KAN Qiming], 2006, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V23, P388